These conflicting results regarding VEGFR1 expression in DKD are difficult to explain; however, we hypothesized that XO inhibition was mediated by the VEGF/VEGFR1 and VEGFR3 axis to enable its biologic actions associated with endothelial function and oxidative stress in DKD. The gene discussed is FLT1; the disease is diabetic kidney disease.